Recent Finacing
Recent Raise
Cereius is a Durham, NC–based biotechnology company developing Duke-licensed radiolabeling chemistries and radionuclide diagnostic and therapeutic products to increase tumor uptake/retention and minimize normal tissue exposure in brain metastases.
